The power of truth
SimVis Gekko patents
2EyesVision international patents
SimVis Gekko is backed by science
The Sim+Vis Technology™ was developed at the Visual Optics and Biophotonics Lab of the Spanish National Research Council (CSIC), a worldwide recognized research institution, and 2EyesVision has licensed the patents with global exclusivity. Several scientific papers have been published about the technology supporting the accuracy, reliability and capabilities of the visual simulator. The clinical application and validation of the visual simulator have also been well established.
SimVis Gekko has demonstrated to be capable of supporting clinical decisions for prescribing multifocal solutions. It is expected to generate increased interest from the scientific community in the coming years, leading to new research avenues and providing evidence in other areas. More than 25 scientific articles have been published after 10+ years of joint research and development:
SIM+VIS TECHNOLOGY IS PROTECTED BY 5 PATENTS
The company has 8 international patents protecting the company’s technology, of which 5 are related to the SimVis Gekko.
Different prestigious institutions from around the world have expressed keen interest in supporting the groundbreaking 2EyesVision project, recognizing its immense potential in revolutionizing the field of vision research and providing the necessary funding and resources to fuel its progress and success. Among these esteemed backers are Bullnet Capital, renowned for their investments in cutting-edge ventures; NextCorps, CDTI-EPE, and the Horizon 2020 program. Additionally, the project has garnered support from the distinguished European Research Council (ERC), the prestigious EIT Health initiative, and the Government of Madrid, alongside other esteemed organizations.